immatics to receive support from Pfizer for its pivotal Phase III study (IMPRINT) with IMA901
immatics, announced that Pfizer are to support its pivotal Phase…
11 April 2011 | By Citigate Dewe Rogerson Ltd
immatics, announced that Pfizer are to support its pivotal Phase III trial (IMPRINT) with IMA901...